Could GLP-1 drugs influence more than appetite? A 48-person trial found signals that semaglutide may affect alcohol consumption and cravings.
It’s early evidence, not an approved treatment. Read beyond the headline.
@longevitytech.bsky.social
@longevitytech.bsky.socialCould GLP-1 drugs influence more than appetite? A 48-person trial found signals that semaglutide may affect alcohol consumption and cravings.
It’s early evidence, not an approved treatment. Read beyond the headline.
@longevitytech.bsky.socialQIMA Life Sciences launches SQINGEVITY, bringing biological testing and clinical studies together to examine claims about skin and hair aging.
Link as first comment.
@longevitytech.bsky.socialArvinas presented early biomarker data on ARV-102, an oral drug built to clear the LRRK2 protein, at a major Parkinson’s meeting.
Link as first comment.
@longevitytech.bsky.socialSmall open-label study of ATR-258 saw fat loss, lean mass gains and better leg power, but no placebo group and just eight weeks long.
Link as first comment.
@ageing.bsky.socialI have been re-elected to the board of Heales- Thank you to our members for their trust.
If you work on healthy ageing in the Commission, the Parliament or civil society: let's talk. EUROSYMPOSIUM ON HEALTHY AGEING In Brussels and online: Nov 5 + 6
#HealthyAgeing #Longevity #Geroscience #EUHealth
@americanaging.bsky.socialA brain protein may act like an aging brake 🧠 In mice, Menin drops with age. Restoring it in 20-month-old mice improved skin, bone and memory in 30 days. Mice only. PLOS Biology 2023. doi.org/10.1371/jour...
#GeroScience
@ageing.bsky.socialFull House👏 Europe’s ageing research now has a federation of its own. Today opens the 1st conference, in Cologne.
The European Federation for Aging Research (EFAR) Hopefully, one voice across borders that can be heard in Brussels.
#Longevity #Geroscience #EUHealth #HealthPolicy #EFARCologne2026
@longevitytech.bsky.socialGLP-1 receptor agonists and BPC-157 may share the peptide conversation, but their evidence is far from equal.
Before believing the hype, ask what was actually studied, in whom, and for how long. Which peptide claim should we examine next?
@longevitytech.bsky.socialA two-year partnership with Ultrahuman aims to connect clinical biomarkers and wearable data, bringing aging assessment into public health.
Link as first comment.
@longevitytech.bsky.socialGPX4-targeting therapy reduces epigenetic age markers and circulating inflammation, raising questions about effects beyond treated skin.
Link as first comment.
@longevitytech.bsky.socialNeither the FDA nor EMA recognizes aging as an indication – but the drafts, the precedent and the people on record are already in the room.
Link as first comment.
@longevitytech.bsky.socialMUST’s RETRO-EPIGERNA team won $1 million and a place in the $81 million finals, though key trial details remain undisclosed.
Link as first comment.
@americanaging.bsky.socialAging may lengthen our lipids 🧬 Chain length rises with age across mice, worms, flies & humans. Knocking down Plb1 in worms reversed it and extended lifespan. Worm data only for lifespan.
doi.org/10.1038/s435...
doi.org/10.1038/s435...
#GeroScience
@longevitytech.bsky.socialCognition Therapeutics will meet the agency on 20 October to agree on how a Phase 3 trial of zervimesine should measure success.
Link as first comment.
#longevity #geroscience #CognitionTherapeutics #Phase3 #zervimesine
@longevitytech.bsky.socialSwedish biotech will present the Phase II ADVANCE trial design for vaccine candidate ALZ-101 at Alzheimer’s disease conference in Boston.
Link as first comment.
@longevitytech.bsky.socialEuropean Parliament conference calls for coordinated action on geroscience, preventive healthcare and healthy aging research.
Link as first comment.
#longevity #geroscience #preventivehealthcare #healthyaging #research
@longevitytech.bsky.socialDeep Longevity’s new US telehealth platform, Accrua, ties treatment plans to a blood-based aging score and re-tests every quarter.
Link as first comment.
@nexthorizonspace.bsky.socialWhy do we age? Aging is a network of DNA damage, senescent cells, inflammation and declining repair — not one biological clock.
www.nexthorizon.space/2026/09/why-...
#Science #Biology #Health #Research #Aging #Longevity #Geroscience #Healthspan
@longevitytech.bsky.socialHepaRegeniX’s darizmetinib clears milestone in major liver resection patients, with favorable safety profile and Phase 2a advance lined up.
Link as first comment.
@longevitytech.bsky.socialFirst-in-human ER-100 data support dose escalation, with early visual-field signals in two of three glaucoma patients.
Link as first comment.
